While, HER2 is overexpressed in a number of cancers, the rate of HER2 amplification is variable in esophageal cancer (10) and few studies have investigated the different features of HER2 gene amplification among ESCC, GEJAC and GC. This evidence concerns the gene ERBB2 and esophageal cancer.